Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans

Journal of Endocrinological Investigation

Volumn 19, Issue 10, 1996, Pages 699-703

  Lunetta, M ^a,c   Di Mauro, M ^a   Le Moli, R ^a   Burrafato, S ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b CIVILE M P AREZZO HOSPITAL   (Italy)

^c GARIBALDI HOSPITAL   (Italy)

Author keywords

Acanthosis nigricans; Hyperinsulinemia; Obesity

Indexed keywords

C PEPTIDE; INSULIN; OCTREOTIDE;

ACANTHOSIS NIGRICANS; ADOLESCENT; ARTICLE; BODY MASS; BODY WEIGHT; CASE REPORT; HUMAN; HYPERINSULINEMIA; INSULIN METABOLISM; MALE; OBESITY; SKIN DEFECT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030473852     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349042     Document Type: Article

References (22)

1. Olefsky J.M., Kolterman O.G. Mechanism of insulin resistance in obesity and in non-msuiin dependent (type II) diabetes. Am. J. Med. 74: 1238, 1984.
2. Stuart C.A., Pate C.J., Peters E.J. Prevalence of acanthosis nigricans in an unselected population. Am. J. Med. 87: 269, 1989.
3. Dunaif A., Graf M., Mandeli J., Laumas V., Dobrjansky A. Characterization of group of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J. Clin. Endocrinol. Metab. 65: 499, 1987.
4. Flier J.S., Eastman R.C., Mmaker K.L., Matteson D., Rowe J.R. Acanthosis nicricans in obese women with hyperandrogenism. Diabetes 34: 101, 1985.
5. Peters E.J., Stuart C.A., Prince M.J. Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action. Metabolism 35: 807, 1986.
6. Cruz P.D., Hud J.A. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J. Invest. Dermatol. 98: 82, 1992.
7. Gavin J.R.III, Roth J., Neville D.M.J.R., De Meyts P., Buell D.N. Insulin-dependent regulation of insulin receptor concentration: a direct demonstration in cell culture. Proc. Natl. Acad. Sci. USA 71: 84, 1974.
8. Bar R.S., Gordon P., Roth J., Kahn C.R., De Meyts P. Fluctuation in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding and dieting. J Clin. Invest. 58: 1123, 1976.
9. Rodin J Insulin levels, hunger, and food intake: an example of feedback loops in body-weight regulation. Health Psychol. 4: 1, 1985.
10. Bauer W., Briner U., Doepfner W., Haller R., Huguenin R., Marbach P., Petcher T.J., Pless J. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31: 1133, 1982.
11. Flier J.S., Usher P., Moses A.C. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblast. Proc. Natl. Acad. Sci. USA 83: 664, 1986.
12. Conover C.A., Hintz R.L., Rosenfeld R.G. Comparative effects of somatomedin C and insulin on the metabolism and growth of cultured human fibrobla. J. Cell. Physiol. 122, 133, 1985.
13. Verrando P., Ortonne J.P. Insulin receptors in cultured human keratinocytes. Br. J. Dermatol. (III, Suppl. 27): 232, 1984.
14. Mirsa P., Nickoloff B.J., Morhenn V.B., Hintz R.L., Rosenfeld R.G. Characterization of insulin-like growth factor-1/somatomedin C receptors on human keratinocyte monolayers. J. Invest. Dermatol. 87: 264, 1986.
15. Verrando P., Ortonne J.P. Insulin binding properties of normal and transformed human epidermal cultured keratinocyte. J. Invest. Dermatol. 85: 328, 1985.
16. Fradkin J.E., Eastman R.C., Lesniak MA, Roth J. Specificity spillover at the hormone receptor-exploring its role in human disease. N. Engl. J. Med. 320: 640, 1989.
17. Field J. Extraction of insulin by the liver. Ann. Rev. Med. 24: 309, 1973.
18. Horwitz D., Star J., Marks M., Blankard W., Rubestein A. Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J. Clin. Invest. 55: 1278, 1975.
19. Giustina A., Bussi A.R., Pizzocolo G., Cimino A., Giustina G. Acute effects of octreotide, a long-acting somatostatin analog, on the insulinemic and glycemic responses to a mixed meal in patients with essential obesity. A dose-response study. Diab. Nutr. Metab. 7: 35, 1994.
20. Wahren J., Eriksson L.S The influence of a long-acting somatostatin analogue on splanchnic haemodinamics and metabolism in healthy subjects and patients with liver cirrhosis. Scand. J. Gastroenterol. 21 (Suppl. 119): 103, 1986.
21. Barnes A.J., Long R.G., Adrian T.E. Effect of a long-acting octapeptide analogue of somatostatin on growth hormone and pancreatic and gastrointestinal hormones in man. Clin. Sci. 61: 653, 1981
22. Johansson C., Wisen O., Efendic S., UvnasWallesten K. Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion 22: 126, 1981.